References
- Tampoia M, Abbracciavento L, Barberio G, et al. A new M23-based ELISA assay for anti-aquaporin 4 autoantibodies: diagnostic accuracy and clinical correlation. Auto Immun Highlights. 2019;10(1):5.
- Ziemssen T, Langdon DW, Calabrese P. Editorial: cognitive disorders in neuroimmun- ological diseases. Front Neurol. 2020;11:169.
- Prabhu MM, Agrawal U. Intractable vomiting and hiccups: an atypical presentation of neuromyelitis optica. Cureus. 2019;11(11):e6245.
- Levy M, Wildemann B, Jarius S, et al. Immunopathogenesis of neuromyelitis optica. Adv Immunol. 2014;121:213–242.
- Li Q, Liu Y, Sun M. Autophagy and Alzheimer’s disease. Cell Mol Neurobiol. 2017;37(3):377–388.
- Xilouri M, Brekk OR, Stefanis L. Autophagy and alpha-synuclein: relevance to Parkinson’s Disease and related synucleopathies. Mov Disord. 2016;31(2):178–192.
- Yang M, Song Y, Zhang HJ, et al. IL-17 inhibits apoptosis of Hep-2 cell lines through modulating PI3K/AKT/FAS/FASL signaling pathway. Acta Universitatis Medicinalis Anhui. 2018;53(11):1681–1684.
- Plaza-Zabala A, Sierra-Torre V, Sierra A. Autophagy and microglia: novel partners in neurodegeneration and aging. J Mol Sci. 2017;18:598.
- Pua HH, Dzhagalov I, Chuck M, et al. A critical role for the autophagy gene Atg5 in T cell survival and proliferation. J Exp Med. 2007;204:25–31.
- Holroyd KB, Manzano GS, Levy M. Update on neuromyelitis optica spectrum disorder. Curr Opin Ophthalmol. 2020;31(6):462–468.
- Frieder J, Kivelevitch D, Haugh I, et al. Anti-IL-23 and Anti-IL-17 biologic agents for the treatment of immune-mediated inflammatory conditions. Clin Pharmacol Ther. 2018;103(1):88–101.
- Kolbinger F, Huppertz C, Mir A, et al. IL-17A and multiple sclerosis: signaling pathways, producing cells and target cells in the central nervous system. Curr Drug Targets. 2016;17(16):1882–1893.
- Misu T, Takahashi T, Nakashima I, et al. Biomarkers in neuromyelitis optica. Brain Nerve. 2012;64(5):525–535.
- Bechara R, Antonios D, Azouri H, et al. Nickel sulfate promotes IL-17A producing CD4+ T cells by an IL-23-dependent mechanism regulated by TLR4 and Jak-STAT pathways. J Invest Dermatol. 2017;137(10):2140–2148.